PEG-BIO Biopharm Co.,Ltd(chongqing).
News Center
Know yourself and Know your Rivals: Here's a look at the Japanese pharmaceutical industry
Source:药事纵横 | Author:pro954f45 | Published time: 2018-03-02 | 1471 Views | Share:

      Although the sales volume of the second and third echelon pharmaceutical enterprises in Japan cannot match that of the first echelon, many of them also have star products. Due to limited globalization capacity, most of the global rights of their products are licensed to pharmaceutical giants in Europe and America, so their sales volume is not high, but their profits are high. They can make a lot of money during the "cash cow" years and then expand rapidly through mergers and acquisitions around the world.
      Although how to break through the "bottleneck" is the top concern of Japan's pharmaceutical giants, some small and medium-sized pharmaceutical companies are following their path. The Japanese drugmakers set to explode in the next few years are Shiono and Ono, and the cash cows that have put them in the top 50 are cold medicine Xofluza and PD-1 monoab Opdivo.
【1-2】Sales Ranking of Listed Pharmaceutical companies in Japan (2016) [1-2]